While each product featured is independently selected by our editors, we may include paid promotion. If you buy something through our links, we may earn commission. Read more about our Product Review ...

At-home diagnostics startup Viome Life Sciences has launched a new test to help detect oral and throat cancers. Oral Health Pro with CancerDetect can detect biomarkers associated with oral and throat ...

A collaboration between Viome Life Sciences and Scripps Research is set to develop and clinically validate the first ribonucleic acid (RNA) test aimed at detecting precancerous colon polyps. This ...

Viome's Full Body Intelligence Test ™ is the only science backed at-home test that decodes your body's biological signals to give you precision health insights. It reveals not just what's happening ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Aug 18, 2023 at 7:21 ...

Study aims to enhance colorectal cancer prevention by identifying polyp molecular signals, offering improved sensitivity over at-home DNA tests, which have limited ability to detect precancerous ...

Viome, maker of at-home test kits for gut, immune and cellular health, has received FDA breakthrough device designation for its mRNA analysis technology and artificial intelligence platform that ...

BELLEVUE, Wash.--(BUSINESS WIRE)--Today, Viome, a longevity company committed to translating scientific advancements into practical and individualized health solutions, has announced the introduction ...

Viome Life Sciences, the leader in AI-powered, RNA-based diagnostics and precision nutrition and Scripps Research, the leader in accelerating the impact of fundamental research on human health, today ...

Built on unique RNA science and cutting-edge AI, Viome's at-home test redefines health by analyzing 100 million biomarkers to detect early signs of biological dysfunction linked to 25+ chronic health ...

First-of-its-kind 1,000-patient clinical study will use RNA-based stool and saliva tests to detect colon polyps — early warning signs of colorectal cancer — before they become cancerous. Study aims to ...